Hyderabad-based AltiusHub raised $2.25 Mn in a seed round led by Endiya Partners to strengthen its engineering team and onboard senior talent.
Founded in 2023 by ex-Darwinbox executives Siddharth Reddy and Abiram Vijaykumar, AltiusHub offers supply chain visibility software, initially targeting the pharma industry.
The platform prevents counterfeit medicines from entering the supply chain through advanced tracking of patterns and anomalies, ensuring product integrity and regulatory compliance.
Hyderabad-based manufacturing supply chain visibility software AltiusHub has raised $2.25 Mn (INR 18.45 Cr) in a seed funding round led by Endiya Partners, along with participation from friends and family.
The funding will be used to further bolster AltiusHub’s engineering team and to onboard sector-specific senior talent.
Founded by former Darwinbox executives Siddharth Reddy and Abiram Vijaykumar in 2023, the platform offers supply chain visibility software that helps manufacturing entities secure their supply chains, with an initial focus on the pharma industry.
The platform helps prevent counterfeit medicines from entering the supply chain through advanced tracking that identifies patterns and anomalies indicating counterfeit activities.
Vijaykumar said, “AltiusHub was born out of a deep-seated concern with the vulnerabilities in traditional supply chains. We saw firsthand the devastating consequences of counterfeit products, particularly in industries like pharmaceuticals.”
Sateesh Andra, managing partner at Endiya Partners, said, “As India’s pharma exports expand, ensuring compliance, visibility, and efficiency across the supply chain is crucial. AltiusHub’s advanced SaaS platform empowers pharma companies to track and trace products from production to final sale while adhering to global regulatory standards.”
AltiusHub’s funding follows a similar raise by Distil, another startup addressing supply chain challenges in the specialty chemicals sector. Distil secured $3.1 Mn (INR 26 Cr) in June.
As per a report, India’s chemical sector, valued at $220 Bn in 2022, is projected to reach $300 Bn by 2025 and $1 Tn by 2040. Both startups aim to tackle inefficiencies in their respective supply chains, reflecting growing investor interest in the sector.
